期刊文献+

脊髓性肌萎缩的基因诊断和产前基因诊断研究 被引量:5

Gene diagnosis and prenatal gene diagnosis of spinal muscular atrophy
原文传递
导出
摘要 目的 探讨中国人脊髓性肌萎缩 (SMA)基因诊断和产前基因诊断的可行性。方法 应用复合聚合酶链反应 -限制性片段长度多态 (PCR -RFLP)方法对 31例SMA患儿进行神经元存活基因 (SMN)第 7外显子缺失分析 ,并对 2例有SMA阳性家族史的家系进行了产前基因诊断。结果  96 8% (30 / 31)SMA患儿携有SMN基因第 7外显子缺失。 2例产前基因诊断的病例均无SMN基因第 7外显子缺失。 Objective To study the feasibility of gene diagnosis and prenatal gene diagnosis in patients with spinal muscular atrophy(SMA).Methods Multiple polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP)was used to dectect the deletions of exogenote 7 of survival motor neuron(SMN)gene in 31 SMA patients.Prenatal diagnosis of SMA was performed in 2 families.Results Homozygous deletion of SMN exogenote 7 was identified in 96\^8%(30/31)of patients with SMA.No deletion of SMN exogenote 7 was found in two cases for prenatal diagnosis.Conclusion This DNA analysis of SMN gene may be useful for gene diagnosis and prenatal gene diagnosis of SMA.
出处 《中国实用儿科杂志》 CSCD 北大核心 2000年第4期219-220,共2页 Chinese Journal of Practical Pediatrics
基金 卫生部 !(96Q -0 40 ) 国家教委 !(97-4 36 ) 辽宁省国际合作项目! (9730 10 )的资助
关键词 脊髓性肌萎缩 产前诊断 基因诊断 Spinal muscular atrophy\ Survival motor neuron gene\ Prenatal diagnosis
  • 相关文献

参考文献5

二级参考文献6

  • 1Chang J G,Am J Hum Genet,1995年,57卷,6期,1053页
  • 2林万明,核酸探针杂交实验技术,1991年,128页
  • 3Wang C H,Hum Mol Genet,1996年,5卷,3期,359页
  • 4Chang J G,Am J Hum Genet,1995年,57卷,1503页
  • 5王柠,临床神经病学杂志,1995年,8期,69页
  • 6陈碧芬,中华病理学杂志,1991年,20卷,38页

共引文献40

同被引文献40

  • 1姚娟,丁新生,沈鸣九,吴芳玲,陈克连,王颖,陈伟贤,李弘钧,侯熙德.聚合酶链反应用于进行性脊髓性肌萎缩的诊断[J].中华检验医学杂志,1998,22(3):4-6. 被引量:2
  • 2Jong YJ, Chang JG, Lin SP, et al. Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients. J Neur Sci, 2000,173:147-153.
  • 3Skordis LA, Dunckley MG, Yue B. Bifuncfional antisense oligonucleotides provide a trans-acting splicing enhancer that simulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA, 2003,100(7):4114-4119.
  • 4DiDonato C J, Parks B J, Kothary R, et al. Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implictions for spinal muscular atrophy therapy. Hum Gene Ther, 2003,14:179-188.
  • 5Monani UR, Sendtner M, Coovert D, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy.Hum Mol Genet, 2000,9(3):333-339.
  • 6Jablonka S, Scharnk B, Kralewski M, et al. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration:an animal model for spinal muscular atrophy type Ⅲ. Hum Mol Genet, 2000,9:341-346.
  • 7Frugier T, Nicole S, Cifuentes-Diaz C, et al. The molecular bases of spinal muscular atrophy. Curr Opin Genet, 2002,12:294-298.
  • 8Frugier T, Tiziano FD, Cifuentes-Diaz C, et al. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet, 2000,9:849-859.
  • 9Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time Lightcycler PCR: fast and hightly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet, 2002,70:358-368.
  • 10Martin Y, Valero A, Samuel I, et al. Genetic study of SMA pateins without homozygous SMN1 deletions: identification of compound beterozygotes and characterization of novel intragenic SMN1 mutation. Hum Gent, 2002,110:257-263,

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部